Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016

被引：0
|
作者：
Roberta Rudà
Alessia Pellerino
Andrea Pace
Carmine Maria Carapella
Cristina Dealis
Manuela Caroli
Marina Faedi
Lorenzo Bello
Enrica Migliore
Giulia Marchese
Luca Bertero
Paola Cassoni
Riccardo Soffietti
机构：
[1] University and City of Health and Science Hospital,Department of Neuro
[2] Cancer Institute,Oncology
[3] Regional Hospital,Department of Neurosurgery
[4] Regional Hospital,Department of Medical Oncology
[5] Regional Hospital,Department of Neurosurgery
[6] University of Milan,Department of Medical Oncology
[7] University of Turin,Department of Neurosurgery
[8] University and City of Health and Science Hospital,Unit of Cancer Epidemiology (CPO Piemonte)
来源：
Journal of Neuro-Oncology | 2019年 / 145卷
关键词：
Grade II gliomas; WHO 2016; Oligodendrogliomas IDH-mutant and 1p/19q codeleted; Temozolomide; Response; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 123
页数：8
相关论文
共 24 条
  • [21] Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT plus PCV in High-risk Low-grade Gliomas
    Bell, E. H.
    Won, M.
    Fleming, J.
    Becker, A.
    McElroy, J.
    Shaw, E. G.
    Mehta, M. P.
    Brachman, D. G.
    Gertler, S.
    Murtha, A. D.
    Schultz, C. J.
    Johnson, D.
    Laack, N. N., II
    Hunter, G. K.
    Crocker, I. R.
    Chakravarti, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S78 - S79
  • [22] Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
    Fisher, Barbara J.
    Pugh, Stephanie L.
    Macdonald, David R.
    Chakravatri, Arnab
    Lesser, Glenn J.
    Fox, Sherry
    Rogers, C. Leland
    Werner-Wasik, Maria
    Doyle, Thomas
    Bahary, Jean-Paul
    Fiveash, John B.
    Bovi, Joseph A.
    Howard, Steven P.
    Yu, Hsiang-Hsuan Michael
    D'Souza, David
    Laack, Nadia N.
    Barani, Igor J.
    Kwok, Young
    Wahl, Daniel R.
    Strasser, Jon F.
    Won, Minhee
    Mehta, Minesh P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (04): : 720 - 725
  • [23] Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT plus PCV in high-risk low-grade gliomas (LGGs).
    Bell, Erica Hlavin
    McElroy, Joseph P.
    Fleming, Jessica
    Timmers, Cynthia Dawn
    Chakraborty, Arup R.
    Salavaggione, Andrea L.
    Shaw, Edward G.
    Aldape, Kenneth D.
    Brachman, David
    Murtha, Albert D.
    Won, Minhee
    Mehta, Minesh P.
    Chakravarti, Arnab
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1P/19Q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT plus PCV IN HIGH RISK LOW-GRADE GLIOMAS
    Bell, Erica H.
    Zhang, Peixin
    Shaw, Edward G.
    Buckner, Jan C.
    Barger, Geoffrey R.
    Coons, Stephen W.
    Bullard, Dennis E.
    Mehta, Minesh P.
    Gilbert, Mark R.
    Brown, Paul D.
    Stelzer, Keith J.
    Fleming, Jessica
    McElroy, Joseph P.
    Timmers, Cynthia D.
    Becker, Aline Paixao
    Salavaggione, Andrea L.
    Liu, Ziyan
    Aldape, Ken
    Brachman, David G.
    Gertler, Stanley Z.
    Murtha, Albert D.
    Schultz, Christopher J.
    Johnson, David
    Shu, Hui-Kuo
    Chakravarti, Arnab
    NEURO-ONCOLOGY, 2017, 19 : 8 - 8
123